Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
Ozcan M, Ustün C, Akçağlayan E, Akan H, Arslan O, Ilhan O, Beksaç M, Gürman G, Demirer T, Arat M, Celebi H, Konuk N, Uysal A, Koç H. Ozcan M, et al. Among authors: demirer t. Bone Marrow Transplant. 2001 Mar;27(5):499-505. doi: 10.1038/sj.bmt.1702816. Bone Marrow Transplant. 2001. PMID: 11313683 Clinical Trial.
A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.
Demirer T, Ilhan O, Mandel NM, Arat M, Günel N, Celebi H, Ustün C, Akan H, Demirer S, Aydintuğ S, Uysal A, Koç H. Demirer T, et al. Among authors: demirer s. Bone Marrow Transplant. 2000 Apr;25(7):697-703. doi: 10.1038/sj.bmt.1702239. Bone Marrow Transplant. 2000. PMID: 10745253 Clinical Trial.
Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF.
Demirer T, Ayli M, Ozcan M, Gunel N, Haznedar R, Dagli M, Fen T, Genc Y, Dincer S, Arslan O, Gürman G, Demirer S, Ozet G, Uysal A, Konuk N, Ilhan O, Koc H, Akan H. Demirer T, et al. Among authors: demirer s. Br J Haematol. 2002 Feb;116(2):468-74. doi: 10.1046/j.1365-2141.2002.03264.x. Br J Haematol. 2002. PMID: 11841454 Free article. Clinical Trial.
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H. Demirer T, et al. Bone Marrow Transplant. 2003 May;31(9):755-61. doi: 10.1038/sj.bmt.1703918. Bone Marrow Transplant. 2003. PMID: 12732881
Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF.
Ozcelik T, Topcuoglu P, Beksac M, Ozcan M, Arat M, Biyikli Z, Bakanay SM, Ilhan O, Gurman G, Arslan O, Demirer T. Ozcelik T, et al. Among authors: demirer t. Bone Marrow Transplant. 2009 Dec;44(12):779-83. doi: 10.1038/bmt.2009.161. Epub 2009 Jul 13. Bone Marrow Transplant. 2009. PMID: 19597420 Clinical Trial.
Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
Ataca Atilla P, Akkus E, Atilla E, Gokmen N, Civriz Bozdag S, Kocak Toprak S, Kurt Yuksel M, Ozcan M, Demirer T, Ilhan O, Beksac M, Akan H, Arslan O, Topcuoglu P, Gurman G. Ataca Atilla P, et al. Among authors: demirer t. Transfus Clin Biol. 2020 Aug;27(3):115-121. doi: 10.1016/j.tracli.2020.06.008. Epub 2020 Jul 10. Transfus Clin Biol. 2020. PMID: 32659269
126 results